Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Integrated Biopharma Inc

+ Add to Watchlist

INBP:US

0.1000 USD 0.0190 23.46%

As of 20:10:05 ET on 04/30/2015.

Snapshot for Integrated Biopharma Inc (INBP)

Open: 0.1000 Day's Range: 0.1000 - 0.1000 Volume: 500
Previous Close: 0.0810 52wk Range: 0.0720 - 0.3400 1-Yr Rtn: -52.38%

Stock Chart for INBP

No chart data available.
  • INBP:US 0.1000
  • 1D
  • 1M
  • 1Y
0.0810
Interactive INBP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INBP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0100
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 2.11
Shares Outstanding (M) 21.11
30 Day Average Volume 2,441
Price/Book (mrq) -
Price/Sale (ttm) 0.0627
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INBP

No data available

Company Profile & Key Executives for INBP

Integrated Biopharma, Inc. develops, manufactures, and distributes biopharmaceutical products worldwide. The Company serves the nutraceutical, biotechnology, and pharmaceutical industries. Integrated provides nutritional supplements and naturally occurring chemotherapeutic anti-cancer agents.

E Gerald KayChairman/President/CEORiva Kay SheppardExecutive VP
Christina KayExecutive VPDina L MasiSenior VP/CFO/Secretary
More Company Profile & Key Executives for INBP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil